Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.
Ticker SymbolBMRA
Company nameBiomerica Inc
IPO dateMar 17, 1980
CEOMr. Zackary S. Irani
Number of employees63
Security typeOrdinary Share
Fiscal year-endMar 17
Address17571 Von Karman Avenue
CityIRVINE
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code92614
Phone19493792875
Websitehttps://biomerica.com/
Ticker SymbolBMRA
IPO dateMar 17, 1980
CEOMr. Zackary S. Irani
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data